Currently a consultant and writer, Deborah Williams has more than 25 years of experience in private industry, trade association and government on polices that directly affect Medicare beneficiaries and providers. Recent publications span from the effect of tariffs on pharmaceuticals, the organization of pharmacies contracting under the 340B program, proposals to reorganize U.S. drug pricing, and others.

In temporal order, Deborah was employed at three of the largest global pharmaceutical companies with key responsibilities integrating federal policy into the launch plans for new pharmaceuticals and legislative analysis and planning on drug pricing and company operations. She spent 6 years as a professional staff member of the Ways and Means Committee, developing and negotiating $2 -3 hundred billion in legislation in the Medicare Modernization Act, Deficit Reduction Act, and the Tax Relief and Heath Care Act of 2006. She conducted full committee oversight hearings on hospital tax exemption, and epogen overdosing. Prior to life as a Congressional staffer, she worked at the American Hospital Association. She was a researcher for two Congressional Commissions, the Office of Research at Centers for Medicare and Medicaid, and the State of Missouri. She has a MS and a BA in economics.